Skip to main content
Why is the market design for innovative pharmaceuticals not well understood?
Read on Becaris
The expanding landscape of digital health and real-world evidence in pharmacoepidemiology: reflections from ISPE 2024
Read on The Evidence Base
Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care
Read on The Lancet
A systematic review of machine learning models for predicting outcomes of stroke with structured data
Read on PLOS ONE
Association of Covid-19 with major arterial and venous thrombotic diseases: A population-wide cohort study of 48 million adults in England and Wales
Read on Circulation, AHA Journals
The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke
Read on Sage Journals
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England
Read on The Lancet
Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Read on PubMed
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
Read on The Lancet
Jump to top
